206 related articles for article (PubMed ID: 10227334)
1. Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial.
Grossman J; Smith LJ; Wilson AM; Thyrum PT
Ann Allergy Asthma Immunol; 1999 Apr; 82(4):361-9. PubMed ID: 10227334
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and tolerability of zafirlukast for the treatment of asthma in children.
Pearlman DS; Lampl KL; Dowling PJ; Miller CJ; Bonuccelli CM
Clin Ther; 2000 Jun; 22(6):732-47. PubMed ID: 10929920
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.
Suissa S; Dennis R; Ernst P; Sheehy O; Wood-Dauphinee S
Ann Intern Med; 1997 Feb; 126(3):177-83. PubMed ID: 9027267
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses.
Tashkin DP; Nathan RA; Howland WC; Minkwitz MC; Simonson SG; Bonuccelli CM
J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):246-54. PubMed ID: 9949315
[TBL] [Abstract][Full Text] [Related]
5. Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.
Fish JE; Kemp JP; Lockey RF; Glass M; Hanby LA; Bonuccelli CM
Clin Ther; 1997; 19(4):675-90. PubMed ID: 9377612
[TBL] [Abstract][Full Text] [Related]
6. Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness.
Nathan RA; Minkwitz MC; Bonuccelli CM
Ann Allergy Asthma Immunol; 1999 May; 82(5):497-503. PubMed ID: 10353583
[TBL] [Abstract][Full Text] [Related]
7. Zafirlukast in clinical practice: results of the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT) in patients with asthma.
Kemp JP; Korenblat PE; Scherger JE; Minkwitz M
J Fam Pract; 1999 Jun; 48(6):425-32. PubMed ID: 10386485
[TBL] [Abstract][Full Text] [Related]
8. An open study to evaluate the safety and efficacy of zafirlukast ("Accolate") in patients with mild to moderate asthma in Ibadan, Nigeria.
Ige OM; Onadeko BO
West Afr J Med; 2001; 20(4):220-6. PubMed ID: 11885876
[TBL] [Abstract][Full Text] [Related]
9. Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.
Nathan RA; Bernstein JA; Bielory L; Bonuccelli CM; Calhoun WJ; Galant SP; Hanby LA; Kemp JP; Kylstra JW; Nayak AS; O'Connor JP; Schwartz HJ; Southern DL; Spector SL; Williams PV
J Allergy Clin Immunol; 1998 Dec; 102(6 Pt 1):935-42. PubMed ID: 9847434
[TBL] [Abstract][Full Text] [Related]
10. Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma.
Kelloway JS
Ann Pharmacother; 1997 Sep; 31(9):1012-21. PubMed ID: 9296243
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma.
Kemp JP; Minkwitz MC; Bonuccelli CM; Warren MS
Chest; 1999 Feb; 115(2):336-42. PubMed ID: 10027429
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the effects of zafirlukast 40 mg b.i.d. in addition to preexisting therapy of high-dose inhaled steroids on symptomatic patients with reversible respiratory obstruction: preliminary data.
Centanni S; Santus P; Casanova F; Di Marco F; Brazzola G; Canonica GW
Drugs Exp Clin Res; 2000; 26(4):133-8. PubMed ID: 11109513
[TBL] [Abstract][Full Text] [Related]
13. Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial.
Silverman RA; Nowak RM; Korenblat PE; Skobeloff E; Chen Y; Bonuccelli CM; Miller CJ; Simonson SG
Chest; 2004 Nov; 126(5):1480-9. PubMed ID: 15539716
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Zafirlukast ('Accolate') in the management of patients with mild-to-moderate asthma.
Chukwu C; Okpapi J; Ige MO; Obodo JO
West Afr J Med; 2000; 19(2):111-9. PubMed ID: 11070746
[TBL] [Abstract][Full Text] [Related]
15. [Leukotriene antagonists--do they have a value?].
Stey C
Praxis (Bern 1994); 2000 Mar; 89(14):586-90. PubMed ID: 10815466
[TBL] [Abstract][Full Text] [Related]
16. Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT).
Korenblat PE; Kemp JP; Scherger JE; Minkwitz MC; Mezzanotte W
Ann Allergy Asthma Immunol; 2000 Feb; 84(2):217-25. PubMed ID: 10719780
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of zafirlukast in the treatment of patients with bronchial asthma.
Tsai JJ; Chan SC; Ho CK; Su YC; Feng TC
J Microbiol Immunol Infect; 2001 Mar; 34(1):63-70. PubMed ID: 11321130
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, safety, and tolerability of mometasone furoate in adult Japanese patients with mild asthma: open-label clinical trial findings.
Tohda Y; Miyamoto T
Curr Med Res Opin; 2010 Jan; 26(1):203-12. PubMed ID: 19921960
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene-receptor antagonists.
Lipworth BJ
Lancet; 1999 Jan; 353(9146):57-62. PubMed ID: 10023966
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study.
Wechsler ME; Ford LB; Maspero JF; Pavord ID; Papi A; Bourdin A; Watz H; Castro M; Nenasheva NM; Tohda Y; Langton D; Cardona G; Domingo C; Park HS; Chapman KR; Mao X; Zhang Y; Khan AH; Deniz Y; Rowe PJ; Kapoor U; Khokhar FA; Mannent LP; Ruddy M; Laws E; Amin N; Hardin M
Lancet Respir Med; 2022 Jan; 10(1):11-25. PubMed ID: 34597534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
